Home Aignostics

Aignostics

In operation
Series B
Developer of Artificial Intelligence Diagnostic Products

Basic Information

Aignostics is an AI-driven precision diagnostic tool focused on pathology to assist in drug development and clinical research. The company specializes in using AI to evaluate complex structures and cell types in H&E, IHC, and Multiplex IF, combined with clinical, molecular, and proteomic data. Our platform is available as a SaaS solution to our customers and supports a wide range of scanners and image modalities, including H&E, IHC, and Multiplex IF.
Aignostics GmbH
Berlin,Berlin,Germany
15~50 people
January 01, 2018
info@aignostics.com